Can I Take 5-HTP with Belsomra (Suvorexant)?
A clinical review of the 5-HTP and suvorexant (Belsomra) interaction: mechanism, serotonin syndrome risk, safe-use guidance, and what to tell your prescriber.
14 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 14 of 14 clinical reviews.
A clinical review of the 5-HTP and suvorexant (Belsomra) interaction: mechanism, serotonin syndrome risk, safe-use guidance, and what to tell your prescriber.
A clinical review of the pharmacokinetic and pharmacodynamic interactions between ashwagandha (KSM-66, Sensoril) and suvorexant (Belsomra), with dosing guidance, monitoring parameters, and safety recommendations.
A guide to the berberine-suvorexant interaction: pharmacokinetics, CYP3A4 inhibition, sedation risk, dosing strategies, and monitoring guidance.
Learn whether caffeine interacts with Belsomra (suvorexant), how the two compounds oppose each other pharmacodynamically, what doses and timing matter, and when to call your prescriber.
A guide to taking calcium supplements with Belsomra (suvorexant). Learn whether any interaction exists, what the evidence shows, and how to time your doses safely.
Evidence-based guide on combining CoQ10 supplements with Belsomra (suvorexant) for insomnia. Covers drug interactions, CYP3A4 metabolism, dose timing, monitoring, and safety data.
A guide to combining glycine supplements with Belsomra (suvorexant), covering interaction mechanisms, safety evidence, dosing, and monitoring guidance.
A guide to combining L-theanine and Belsomra (suvorexant): mechanism, interaction type, safety evidence, dose timing, and when to call your prescriber.
A clinical review of the magnesium-suvorexant interaction: pharmacokinetics, pharmacodynamics, safety data, dosing guidance, and monitoring recommendations for patients combining these two sleep aids.
A clinical review of the melatonin and Belsomra (suvorexant) interaction: mechanism, safety, dosing, and what your prescriber needs to know before you combine them.
A guide to the pharmacokinetic and pharmacodynamic interactions between reishi mushroom and suvorexant (Belsomra), with dosing context, monitoring advice, and practical clinical guidance.
A clinical review of the resveratrol, suvorexant interaction: CYP3A4 inhibition, pharmacokinetic risks, dosing guidance, and monitoring recommendations for patients taking Belsomra.
A guide covering the pharmacokinetic and pharmacodynamic interaction profile between suvorexant (Belsomra) and vitamin B12, including dosing timing, monitoring, and safety guidance.
A guide to taking vitamin B6 with Belsomra (suvorexant): pharmacokinetic and pharmacodynamic interaction data, safe dose ranges, monitoring guidance, and when to call your prescriber.